[ET Net News Agency, 20 February 2025] Nomura raised the target price for Wuxi Bio
(02269) to HKD30.59 from HKD19.3 and maintained the "buy" rating.
The research house said it expects Wuxi Bio registered 16.2% y-y sales growth to
CNY9.9bn in 2H24F. (rc)